Velosbio
San Diego, US · Founded 2017 · Delaware corporation · 5 known investors
A biopharmaceutical company developing medicines and vaccines with a focus on clinical research and development for human health.
Founders & leadership
Velosbio was founded in 2017 by David Johnson.
DJ
David JohnsonFounder
CG
Cam GallagherNamed on SEC filing
SL
Scott L. GlennNamed on SEC filing
Investors · 5
Reported raises · per SEC filings
Form D private placements$210.5M disclosed across 4 rounds · 2018–2020
▶$137MraisedJul 2020 · 38 investors · BiotechnologyRule 506(b)
▶$137MraisedJul 2020 · 38 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Min CuiDirector
- Jayson PunwaniDirector
- Karan TakharDirector
- Alan ColowickDirector
- Cam GallagherDirector
- Clayton KnoxExecutive Officer
- Jonathan TobinDirector
- David JohnsonExecutive Officer, Director
- Scott KarchmerExecutive Officer
- Langdon MillerExecutive Officer
- Offering amount
- $137M
- Amount sold
- $137M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$59.3MraisedMay 2020 · 38 investors · BiotechnologyRule 506(b)
▶$59.3MraisedMay 2020 · 38 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott KarchmerExecutive Officer
- Jonathan TobinDirector
- Langdon MillerExecutive Officer
- Alan ColowickDirector
- David JohnsonExecutive Officer, Director
- Jayson PunwaniDirector
- Min CuiDirector
- Clayton KnoxExecutive Officer
- Cam GallagherDirector
- Offering amount
- $59.3M
- Amount sold
- $59.3M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$6.5MraisedJul 2018 · 2 investors · BiotechnologyRule 506(b)
▶$6.5MraisedJul 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Min CuiDirector
- David JohnsonExecutive Officer, Director
- Jayson PunwaniDirector
- Scott L. GlennDirector
- Cam GallagherDirector
- Offering amount
- $6.5M
- Amount sold
- $6.5M
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$7.7MraisedFeb 2018 · 12 investors · BiotechnologyRule 506(b)
▶$7.7MraisedFeb 2018 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David JohnsonExecutive Officer, Director
- Cam GallagherDirector
- Scott L. GlennDirector
- Offering amount
- $7.7M
- Amount sold
- $7.7M
- Proceeds to insiders
- $350K
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Velosbio do?
- A biopharmaceutical company developing medicines and vaccines with a focus on clinical research and development for human health.
- Who founded Velosbio?
- Velosbio was founded by David Johnson in 2017.
- Who are Velosbio's investors?
- Velosbio's investors include Chiesi Ventures, Pappas Capital, Sofinnova Ventures, Vedanta Capital, OrbiMed.
- How much funding has Velosbio raised?
- Velosbio has disclosed $210.5M raised across 4 rounds.
- Where is Velosbio headquartered?
- Velosbio is headquartered in San Diego, US.